Search research articles
Contact Us
Filters
Showing results (521-530 of 688) with videos related to
Page
of 69
Sort By:
Circulation
|
March 15, 2006
The Seattle Heart Failure Model: prediction of survival in heart failure
Wayne C Levy, Dariush Mozaffarian, David T Linker, et al.
International Journal of Cardiology
|
December 1, 2012
Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT
Sally C Inglis, Judith Bebchuk, Sultan A Al-Suhaim, et al.
Journal of the American College of Cardiology
|
October 19, 2004
Task force 2: Investigator participation in clinical research
Robert M Califf, Steven E Nissen, Anthony N DeMaria, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 17, 2023
Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis
Pantelis Sarafidis, Rajiv Agarwal, Bertram Pitt, et al.
International Journal of Cardiology
|
February 4, 2023
Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials
João Pedro Ferreira, John G Cleland, Nicolas Girerd, et al.
Kidney Medicine
|
December 4, 2023
Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials
John M Flack, Rajiv Agarwal, Stefan D Anker, et al.
Journal of the American College of Cardiology
|
December 3, 2014
Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction
Robert J Mentz, Jacob P Kelly, Thomas G von Lueder, et al.
JAMA Cardiology
|
August 25, 2018
Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial
Peder Langeland Myhre, Muthiah Vaduganathan, Brian L Claggett, et al.
JACC. Heart Failure
|
November 30, 2019
Influence of Age on Efficacy and Safety of Spironolactone in Heart Failure
Orly Vardeny, Brian Claggett, Muthiah Vaduganathan, et al.
Archives of Internal Medicine
|
January 14, 2004
Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses
Charles H Hennekens, Frank M Sacks, Andrew Tonkin, et al.
Page
of 69
Search research articles
Search
Showing results (521-530 of 688) with videos related to
Sort By:
Page
of 69
Circulation
|
March 15, 2006
The Seattle Heart Failure Model: prediction of survival in heart failure
Wayne C Levy, Dariush Mozaffarian, David T Linker, et al.
International Journal of Cardiology
|
December 1, 2012
Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT
Sally C Inglis, Judith Bebchuk, Sultan A Al-Suhaim, et al.
Journal of the American College of Cardiology
|
October 19, 2004
Task force 2: Investigator participation in clinical research
Robert M Califf, Steven E Nissen, Anthony N DeMaria, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 17, 2023
Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis
Pantelis Sarafidis, Rajiv Agarwal, Bertram Pitt, et al.
International Journal of Cardiology
|
February 4, 2023
Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials
João Pedro Ferreira, John G Cleland, Nicolas Girerd, et al.
Kidney Medicine
|
December 4, 2023
Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials
John M Flack, Rajiv Agarwal, Stefan D Anker, et al.
Journal of the American College of Cardiology
|
December 3, 2014
Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction
Robert J Mentz, Jacob P Kelly, Thomas G von Lueder, et al.
JAMA Cardiology
|
August 25, 2018
Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial
Peder Langeland Myhre, Muthiah Vaduganathan, Brian L Claggett, et al.
JACC. Heart Failure
|
November 30, 2019
Influence of Age on Efficacy and Safety of Spironolactone in Heart Failure
Orly Vardeny, Brian Claggett, Muthiah Vaduganathan, et al.
Archives of Internal Medicine
|
January 14, 2004
Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses
Charles H Hennekens, Frank M Sacks, Andrew Tonkin, et al.
Page
of 69